Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -9.116\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a COc1cc(NC(=S)Nc2ncccc2C)cc(OC)c1OC
b Cc1ccsc1/C=N/NC(=O)Cc1cccn1C
c COc1cccc(CN2CCNC(=O)C2CC(=O)NCCCn2ccnc2)c1
d Cc1ccc(-c2nn3c(C)nnc3s2)cc1NC(=O)c1cccnc1
Answer: d. Cc1ccc(-c2nn3c(C)nnc3s2)cc1NC(=O)c1cccnc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-c2nn3c(C)nnc3s2)cc1NC(=O)c1cccnc1
Cc1ccc(-c2nn3c(C)nnc3s2)cc1NC(=O)c1cccnc1
N-[2-methyl-5-(3-methyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl)phenyl]pyridine-3-carboxamide